CellSystems
CellSystems GmbH is a German life science products distributor that sells research reagents, primary cells, culture media, enzymes, and iPSC research products and services to academic researchers, biotechnology firms, and pharmaceutical companies across Europe and globally.
- Company typePrivate
- Founded1992
- HeadquartersTroisdorf, Germany
- Headcount1–10
- GTM typeB2B
- OfferingServices
What CellSystems does
CellSystems GmbH is a privately held German life science products distributor headquartered in Troisdorf, Germany, operating since approximately 1992 with 1-10 employees. The company functions as a specialty aggregator and reseller of research reagents, primary cells, culture media, tissue dissociation enzymes, matrix proteins, antibodies, and molecular biology products sourced from a portfolio of brand partners including Worthington Biochemical, Lifeline Cell Technology, Applied StemCell, Advanced BioMatrix, BioSurfaces, Minerva Biotechnologies, and Prolytix. Its own branded and co-marketed sub-brands include ActiCells™, TARGATT™, RatCol®, FibroLife®, Bio-Spun™, SCAT, NUCxyme™, AlphaSTEM®, and the PureCol® collagen product family, the latter cited in over 2,000 scientific publications.
The company's technical differentiation is concentrated in its iPSC research portfolio, built around a long-standing strategic partnership with Applied StemCell. This relationship gives CellSystems access to proprietary gene editing platforms (TARGATT™ site-specific large knock-in up to ≥50 kb at the H11 safe harbor locus, SSelect™, CRISPR-Cas9 RACE™ protocols, AccuBase base editing, and royalty-free MAD7), hypoimmunogenic hiPSC platforms (B2M/CIITA dual knockout derived from CD34+ umbilical cord blood cells), and fee-for-service iPSC generation (>95% efficiency), differentiation, and custom cell line development under ISO 9001 and ISO 13485 quality systems.
CellSystems operates a direct-to-consumer B2B e-commerce model through its website, with global shipping from Germany and a horizontal customer segmentation across academic researchers, biotechnology companies, and pharmaceutical companies. Revenue is generated primarily through one-time catalog sales of research reagents and consumables at unit pricing, supplemented by professionally serviced iPSC projects quoted via contact form. Distribution is direct-only with no disclosed API, software integration, or third-party reseller channel, and the company is privately held with no disclosed funding rounds, acquisitions, or institutional investors.
CellSystems firmographics
Firmographics- Name
- CellSystems
- Legal name
- CellSystems GmbH
- Website
- https://cellsystems.eu
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- CellSystems GmbH is a German life science products distributor that sells research reagents, primary cells, culture media, enzymes, and iPSC research products and services to academic researchers, biotechnology firms, and pharmaceutical companies across Europe and globally.
- Ownership category
- akta.pro rank
CellSystems industry classification
Industry- Product category
- Life Science Research Reagents and Consumables
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables) (HLAAABAH)
- akta.pro secondary industry
- Cell Therapy Enabling Technologies (gene editing, cell engineering, delivery methods) (HLAAABAL)
Keywords
Where CellSystems is headquartered
LocationHeadquarters
- HQ city
- Troisdorf
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
CellSystems business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Research Reagents and Consumables Sales: Sale of life science products including primary cells, culture media, enzymes, tissue dissociation reagents, matrix proteins, antibodies, and molecular biology products. Products sourced from multiple brand partners and sold through e-commerce platform.
- iPSC Research Services: Fee-for-service offerings including iPSC generation, differentiation, genome editing, and custom cell line development. Services provided in collaboration with Applied StemCell. Includes GMP-compliant service options.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Research-use products sold at catalog pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
CellSystems product offering
Product offeringCore offering
CellSystems GmbH is a life science products distributor that supplies primary cells, cell culture media, tissue dissociation enzymes, collagen and matrix proteins, iPSC research products, molecular biology reagents, antibodies, and haemostasis research consumables to academic and commercial research customers. In addition to catalog reagent sales, the company offers specialized iPSC services (generation, differentiation, and gene editing) delivered in partnership with Applied StemCell, including proprietary platforms such as TARGATT™ large knock-in technology and hypoimmunogenic ActiCells™ hiPSC lines.
Product overview
CellSystems® is a life science products distributor and supplier offering a comprehensive portfolio across nine major product categories: Primary Cells & Culture Media, Tissue Dissociation, Matrix Proteins/Bioprinting, iPSC Research, Cell Signaling, Molecular Biology, Antibodies, and Haemostasis & Thrombosis. The company distributes its own branded products alongside offerings from established supplier brands including Worthington Biochemical, Lifeline Cell Technology, Applied StemCell, Advanced BioMatrix, BioSurfaces, Minerva Biotechnologies, and Prolytix (formerly Haematologic Technologies). Their iPSC research portfolio is particularly extensive, featuring engineered cell lines (ActiCells™, AlphaSTEM® Naïve iPSCs), proprietary gene editing technologies (TARGATT™, SSelect™, AccuBase, MAD7, CRISPR-Cas9), and comprehensive services including iPSC generation, differentiation, and custom cell line development. The company also offers extensive molecular biology reagents, collagen-based matrix proteins, and specialized blood collection tubes for coagulation research. CellSystems operates exclusively as a product supplier without any API or software integration capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- ActiCells™: Hypoimmunogenic hiPSC platforms for allogeneic research
- TARGATT™
- RatCol®
- FibroLife®
- Bio-Spun™
- SCAT
- NUCxyme™
- AlphaSTEM®
- AdipoLife™
- StemLife MSC
- BronchiaLife™
- Cytus™
- PureCol®
- VitroCol®
- TeloCol™
- Vasculife
- TrypKit™
- Lifeline®
- ChondroLife™
- ReproLife™
- FibroLife S2
- iMGLs
Products and services
- Primary Cells & Culture Media Catalog of primary human cells and matched serum-free growth, differentiation, and subculture media for routine and specialized cell culture workflows, sold to academic and commercial life science laboratories.
- Tissue Dissociation Enzymes & Kits Enzymes and complete tissue dissociation kits for releasing cells from tissues, sourced from Worthington Biochemical and other suppliers, for primary cell isolation and cell biology research.
- Matrix Proteins & Bioprinting Supplies Extracellular matrix proteins, collagen variants, and 3D scaffolds for 3D cell culture, hydrogel formation, and bioprinting research, distributed from Advanced BioMatrix and BioSurfaces.
- iPSC Research Products & Gene Editing Platforms Comprehensive iPSC research product range covering engineered cell lines, differentiation kits, feeder cells, media, and proprietary site-specific genome editing platforms for iPSC engineering and cell therapy research.
- Cell Signaling Reagents Cytokines, chemokines, growth factors, neurotrophins, and CD antigens for cell signaling and stem cell research applications.
- Molecular Biology Reagents Molecular biology enzymes and reagents including nucleases (DNase, RNase, NUCxyme™), proteases (Proteinase K), reverse transcriptase, alkaline phosphatase, and other enzymes for nucleic acid research.
- Research Antibodies Research antibodies for coagulation, immunology, and cell biology applications.
- Haemostasis & Thrombosis Research Products Coagulation proteins, factor-deficient plasmas, bone-related proteins, fluorogenic substrates/inhibitors, and custom SCAT blood collection tubes (SCAT-1, SCAT-2, SCAT-875B, CTI, ACT) for haemostasis and thrombosis research, distributed from Prolytix.
- ActiCells™ Hypoimmunogenic hiPSC Platform Transgene-free, well-characterized hypoimmunogenic human iPSC line with B2M/CIITA dual knockout, plus a matched TARGATT™ knock-in kit, designed for allogeneic cell therapy and gene editing research.
- TARGATT™ Large Knock-in Technology & Kits Proprietary integrase-mediated site-specific genome editing platform and ready-to-use kits (Female hiPSC Knock-in Kit, GMP-Matching RUO Knock-in Kit, Hypo hiPSC Knock-in Kit) for stable single-copy transgene insertion at the H11 safe harbor in mammalian genomes.
- Bio-Spun™ 3D Scaffolds Animal-free electrospun nanofibrous 3D scaffolds mimicking extracellular matrix for advanced tissue and organ model applications, available in multiple polymer formats and well-plate insert sizes.
- iPSC Generation Services Custom iPSC generation from PBMCs, fibroblasts, HSCs, MSCs, CD34+ cord blood, or urine cells using multiple reprogramming methods, delivered by Applied StemCell with 15+ years of expertise.
- iPSC Differentiation Services Custom iPSC differentiation into multiple lineages for disease modeling, drug discovery, and cell therapy research, delivered with non-integrating protocols.
- CRISPR-Cas9 Gene Editing Services Custom CRISPR-Cas9 gene editing services for knock-out, knock-in, and point mutations in iPSCs, delivered with optimized RACE™ protocols by Applied StemCell.
- TARGATT™ Master Cell Line Generation Service Custom contract service for generating master cell lines with site-specific gene insertion via TARGATT™ technology in mammalian cells (human, mouse, rat, other).
Quantifiable outcome
- >95% iPSC generation efficiency
- +3 more outcomes
Companies that use CellSystems
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
CellSystems technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
CellSystems partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Applied StemCellcoreLong-standing strategic partnership for iPSC generation, differentiation, genome editing, and custom cell line development services. Applied StemCell provides ISO 9001 and ISO 13485 certified services including TARGATT™, CRISPR-Cas9, SSelect™, AccuBase, and MAD7 gene editing technologies. They have developed over 1,800 unique engineered cell line models.
- Advanced BioMatrixcoreDistribution partner for Advanced BioMatrix collagen products including PureCol®, VitroCol®, TeloCol®, and related matrix proteins. Products include collagen-coated plates and 3D hydrogel products. Co-exhibited together at TERMIS 2025.
- Prolytix (formerly Haematologic Technologies)minorDistribution partner for SCAT (Sample Collection/Anticoagulant Tubes) blood collection tubes for clinical research applications. Includes custom tube manufacturing and OEM contract manufacturing capabilities.
- Minerva BiotechnologiesminorDistribution partner for AlphaSTEM® Naïve hPSC products including culture media, differentiation inducers, and iPSC cell lines derived from various sources.
- Worthington BiochemicalcoreLong-standing distribution partner for Worthington enzyme products including collagenase, dispase, DNase, RNase, protease, and other molecular biology enzymes. Major brand portfolio including CLS-2 Collagenase Type 2 and Proteinase K.
- Lifeline Cell TechnologycoreDistribution partner for Lifeline® cell culture products including Trypsin/EDTA solutions, xeno-free reagents, growth media, and cell culture supplements.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
CellSystems competitors and assessment
Company assessmentBroad incumbents
- Sartorius AG: Major German bioprocessing supplier offering cell line development, cell culture media, and cell therapy manufacturing solutions. Comparable end markets and German hub, but a much broader and manufacturer-led portfolio than CellSystems' specialized reagent distribution.
- Bio-Techne: US-based broad life science tools supplier covering proteins, antibodies, cell culture reagents, and iPSC/gene editing tools. Overlaps with CellSystems' catalog across cell signaling, matrix proteins, and iPSC product lines, but at much larger scale and with majority manufacturer-direct reach.
Regional players
- Tebu-Bio: France-based specialist life science distributor supplying reagents, antibodies, cell biology kits, and OEM/custom services across Europe. Same niche distribution positioning as CellSystems but with primary geographic emphasis on France/Benelux rather than Germany.
Emerging players
- CellGenix GmbH: German supplier of GMP-manufactured cytokines, growth factors, and cell culture reagents for cell and gene therapy manufacturing. Comparable cell-therapy-adjacent reagent catalog and German-based; complements rather than mirrors CellSystems' research-grade emphasis.
- Axol Bioscience (combined with bit.bio): Supplier of iPSC-derived cell lines (neurons, cardiomyocytes, microglia) and iPSC reprogramming services — directly comparable to CellSystems' iPSC-derived cells (iMGLs, cardiomyocytes, NK cells, RPE) and Applied StemCell-enabled differentiation services.
Direct peers
- Carl Roth GmbH + Co. KG: German specialist distributor of chemicals, reagents, and life science consumables serving academic and industrial research customers. Highly comparable business model: curated multi-brand catalog, e-commerce storefront, and concentration on the German/European research market.
- STEMCELL Technologies: Canada-headquartered specialist in cell culture media, primary cells, iPSC reagents, and cell separation products — a direct overlap with CellSystems' primary cells, iPSC research, and cell culture media categories, though STEMCELL is significantly larger and manufacturer-led.
- Reprocell: Japan-based supplier of iPSC and stem cell products, reagents, and services — directly comparable to CellSystems' iPSC research portfolio (AlphaSTEM/ActiCells lines and Applied StemCell gene editing services). Competes in the same translational iPSC category.
- Dunn Labortechnik GmbH & Co. KG: German distributor specializing in laboratory reagents and life science consumables for academic and biotech customers. Closely mirrors CellSystems' positioning as a small German specialist with multi-brand reagent portfolio and direct e-commerce sales.
- Th. Geyer GmbH & Co. KG: German distributor of laboratory chemicals, life science reagents, and diagnostic products with a multi-brand catalog model very similar to CellSystems. Comparable mix of own-label lines and third-party principal brands distributed through direct sales and e-commerce.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
CellSystems social profiles
Digital presenceCellSystems compliance and trust
Trust signalCompliance2 records
CellSystems financial estimates
Financial estimateRevenue estimate
Valuation estimate
CellSystems leadership team
Management profileNumber of profiles
Profiles1 record
CellSystems funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CellSystems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CellSystems
What does CellSystems do?
CellSystems GmbH is a life science products distributor that supplies primary cells, cell culture media, tissue dissociation enzymes, collagen and matrix proteins, iPSC research products, molecular biology reagents, antibodies, and haemostasis research consumables to academic and commercial research customers. In addition to catalog reagent sales, the company offers specialized iPSC services (generation, differentiation, and gene editing) delivered in partnership with Applied StemCell, including proprietary platforms such as TARGATT™ large knock-in technology and hypoimmunogenic ActiCells™ hiPSC lines.
Is CellSystems a public or private company?
CellSystems is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was CellSystems founded?
CellSystems was founded in 1992. It employs 1 to 10 people.
Where is CellSystems based?
CellSystems is headquartered in Troisdorf, Germany, in the Europe region.
How does CellSystems make money?
Two revenue lines are on record. Research Reagents and Consumables Sales are the primary driver. The others are iPSC Research Services.
Who are CellSystems's main competitors?
Broad incumbents on record are Sartorius AG and Bio-Techne. Tebu-Bio is listed as a regional player. Emerging players are CellGenix GmbH and Axol Bioscience (combined with bit.bio). Direct peers are Carl Roth GmbH + Co. KG, STEMCELL Technologies, Reprocell, Dunn Labortechnik GmbH & Co. KG and Th. Geyer GmbH & Co. KG.
Does CellSystems have an API?
No public API is recorded for CellSystems.
What industry is CellSystems in?
CellSystems's product category is Life Science Research Reagents and Consumables. Its primary akta.pro industry code is HLAAABAH, Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables), with a secondary code of HLAAABAL, Cell Therapy Enabling Technologies (gene editing, cell engineering, delivery methods). Its NAICS code is 541714 and its SIC code is 8731.